We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTXR icon
226
First Trust Nasdaq Transportation ETF
FTXR
$1.06B
$41.2K ﹤0.01%
1,385
-1,150
-45% -$31.1K
EPM icon
227
Evolution Petroleum
EPM
$127M
$40.4K ﹤0.01%
5,000
– –
NKE icon
228
Nike
NKE
$62.3B
$40K ﹤0.01%
362
– –
XYZ
229
Block Inc
XYZ
$47B
$39.9K ﹤0.01%
600
– –
IEMG icon
230
iShares Core MSCI Emerging Markets ETF
IEMG
$155B
$39.1K ﹤0.01%
793
– –
CTVA icon
231
Corteva
CTVA
$51.3B
$38.9K ﹤0.01%
679
– –
SWKS icon
232
Skyworks Solutions
SWKS
$10.1B
$38.9K ﹤0.01%
351
– –
EVRG icon
233
Evergy
EVRG
$19.1B
$38.3K ﹤0.01%
655
– –
ITCI
234
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$38K ﹤0.01%
600
– –
TMUS icon
235
T-Mobile US
TMUS
$193B
$37.8K ﹤0.01%
272
+66
+32% +$9.26K
TOTL icon
236
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.02B
$37.4K ﹤0.01%
922
– –
BIL icon
237
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$36.7K ﹤0.01%
400
– –
SLQT icon
238
SelectQuote
SLQT
$120M
$35.6K ﹤0.01%
18,241
– –
EEFT icon
239
Euronet Worldwide
EEFT
$2.73B
$35.2K ﹤0.01%
300
– –
IVT icon
240
InvenTrust Properties
IVT
$2.6B
$34.2K ﹤0.01%
1,476
– –
ADM icon
241
Archer Daniels Midland
ADM
$37.4B
$31K ﹤0.01%
410
– –
WH icon
242
Wyndham Hotels & Resorts
WH
$5.58B
$30.7K ﹤0.01%
448
– –
AZO icon
243
AutoZone
AZO
$50.1B
$29.9K ﹤0.01%
12
+2
+20% +$5.1K
INTU icon
244
Intuit
INTU
$88.1B
$29.8K ﹤0.01%
65
– –
GTY
245
Getty Realty Corp
GTY
$2.06B
$29.7K ﹤0.01%
879
– –
VHT icon
246
Vanguard Health Care ETF
VHT
$18.4B
$29.6K ﹤0.01%
121
– –
ISEE
247
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$29.5K ﹤0.01%
750
– –
KTB icon
248
Kontoor Brands
KTB
$4.36B
$29.5K ﹤0.01%
701
– –
SBUX icon
249
Starbucks
SBUX
$120B
$29.1K ﹤0.01%
294
+87
+42% +$9.03K
IEF icon
250
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
$29K ﹤0.01%
300
– –
8 9
10
11 12

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.